Detalhe da pesquisa
1.
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancer.
Cancer
; 130(10): 1758-1765, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38422026
2.
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
Hum Genomics
; 17(1): 66, 2023 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461096
3.
Correction: Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
Hum Genomics
; 17(1): 74, 2023 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580755
4.
Oncogene-driven non-small cell lung cancers in patients with a history of smoking lack smoking-induced mutations.
Cancer Res
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587551
5.
Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate Measure.
JTO Clin Res Rep
; 4(12): 100599, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38162173
6.
PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancer.
Eur J Cancer
; 178: 139-149, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36436331
7.
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance.
Transl Lung Cancer Res
; 12(4): 742-753, 2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37197627
8.
Inferring cancer disease response from radiology reports using large language models with data augmentation and prompting.
J Am Med Inform Assoc
; 30(10): 1657-1664, 2023 09 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451682
9.
Refining patient selection of MET-activated non-small cell lung cancer through biomarker precision.
Cancer Treat Rev
; 110: 102444, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108503
10.
Dietary factors and the risk of lung cancer by epidermal growth factor receptor mutation status and histological subtypes.
Front Public Health
; 10: 1079543, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36530673
11.
Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 6: e2200278, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240473
12.
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC.
JTO Clin Res Rep
; 3(12): 100416, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36426287
13.
Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
JAMA Netw Open
; 4(11): e2131892, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739062
14.
Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities.
Clin Cancer Res
; 27(21): 5939-5950, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261696
15.
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC.
J Thorac Oncol
; 15(12): 1928-1934, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32866654
16.
Impact of Cryotherapy on Sensory, Motor, and Autonomic Neuropathy in Breast Cancer Patients Receiving Paclitaxel: A Randomized, Controlled Trial.
Front Neurol
; 11: 604688, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33424755
17.
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
Lung Cancer
; 139: 207-215, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31835042
18.
Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma.
Am J Hematol
; 84(7): 414-7, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19415727
19.
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.
J Clin Oncol
; 37(11): 876-884, 2019 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30676858
20.
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.
Nat Rev Clin Oncol
; 15(3): 150, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29182164